GLP-1 Drugs Have Long-Term Benefit for Heart Health, Review Suggests

GLP-1 drugs have long-term benefit for heart health, review suggests

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes, and premature death over a sustained period of time. Researchers from Anglia Ruskin University (ARU) analyzed data from more than 90,000 patients enrolled in large-scale international studies and found that people given glucagon-like peptide‑1 (GLP‑1) receptor agonists were significantly less likely to suffer major cardiovascular events than th…

GLP-1 Medications Offer Lasting Cardiovascular Benefits, New Research Shows

Groundbreaking research now shines a spotlight on the profound cardiovascular benefits of GLP-1 receptor agonists, a class of drugs primarily recognized for their efficacy in weight management and diabetes control. This new systematic review and meta-analysis, conducted by researchers at Anglia Ruskin University, has meticulously examined data from over 90,000 patients involved in large-scale international […]